In-Home ADHD Testing

For telehealth evaluations, we use the IVA-2 CPT for in-home ADHD testing. This computerized performance test measures attention and response control, offering objective data from the convenience of the patient's home. 

The IVA-2 CPT (Integrated Visual and Auditory Continuous Performance Test) is an advanced and reliable Clinical Decision Support (CDS) tool specifically designed to assess symptoms of attention-deficit/hyperactivity disorder (ADHD) in individuals. Aspire ADHD offers the IVA-2 for further testing of ADHD to support mental health clinicians and their clients in accurate diagnosis and subsequent treatment. The IVA-2 is a Clinical Decision Support software, which supplements a clinical interview. It provides an objective and standardized evaluation of attention and impulse control, utilizing both visual and auditory stimuli. This comprehensive assessment allows for a more accurate understanding of cognitive functioning, going beyond subjective observations and self-reported symptoms.

Further, the IVA-2 is unique in that it provides Malingering Analysis to help a clinician determine if a client is feigning impairments or symptoms of ADHD for personal gain. The IVA-2 is an essential piece to a thorough assessment process that can contribute to a more precise diagnosis. A precise diagnosis is vital in tailoring an appropriate treatment plan for an individual’s specific needs, ensuring they receive the most effective interventions and support. Moreover, the IVA-2's results can provide valuable insights into an individual’s performance on different attention-related measures, such as sustained attention, response control, and response variability. This comprehensive understanding can guide the therapeutic approach to develop targeted interventions to address specific challenges the individual may be facing.

Here’s a summary of the diagnostic accuracy of the IVA CPT (Integrated Visual and Auditory Continuous Performance Test) for ADHD:

• Sensitivity: 92% (the ability of the test to correctly identify individuals with ADHD)
• Specificity: 90% (the ability of the test to correctly identify individuals without ADHD)
• Positive Predictive Power: 89% (the likelihood that someone who tests positive on the IVA CPT actually has ADHD)
• Negative Predictive Power: 93% (the likelihood that someone who tests negative does not have ADHD)

The IVA CPT was also compared with other diagnostic tools like the TOVA (Test of Variables of Attention), GORDON, and CAS (Conners' Continuous Performance Test), showing high agreement in diagnosing ADHD, with rates up to 100% when matched against certain tools. This suggests the IVA CPT has strong concurrent validity, meaning it performs well alongside other established ADHD diagnostic instruments. 

This level of diagnostic accuracy supports the IVA CPT's utility as a reliable tool for ADHD assessment, complementing traditional clinical evaluations and enhancing diagnostic precision.

Please note, the IVA-2 CPT is not intended to replace a full neuropsychological evaluation and may not be sufficient testing for certain individuals. It is important to consult with a trained clinician or the entity requesting testing to be certain IVA-2 CPT is the correct testing for your specific needs. Additionally, results do not guarantee particular treatment but serve to guide a clinician’s treatment plan. Treatment is individualized and determined by multiple factors.

IVA-2 CPT Service Pricing

Reserved testing session including report: 

• With insurance $300.00
• Self-Pay $450.00

Despite the value of the IVA-2 to promote more targeted treatment plans, potentially reducing trial-and-error approaches and unnecessary interventions, the administration of the test and generation of the report are not reliably reimbursed by commercial insurances. However, market research demonstrates that this cost is significantly more affordable than typical out-of-pocket costs for neuropsychological testing.